查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948216

2026年全球智慧切片检查设备市场报告

Smart Biopsy Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，智慧切片检查设备的市场规模显着成长，预计2025年将达到30.1亿美元，到2026年将达到32.3亿美元，复合年增长率为7.2%。过去几年的增长可归因于癌症发病率的上升、微创诊断程序的广泛应用、先进诊断成像基础设施的扩展、核心针穿刺活检技术的日益普及以及临床医生在影像引导诊断方面培训的加强。

预计未来几年智慧切片检查设备市场规模将强劲成长，2030年将达到43.2亿美元，复合年增长率（CAGR）为7.6%。预测期内的成长将主要受以下因素驱动：对精准癌症诊断的需求不断增长、对智慧外科技术的投资增加、机器人辅助介入平台的扩展、对早期疾病检测的日益重视以及人工智能驱动的诊断支持的日益普及。预测期内的关键趋势包括：影像引导切片检查系统的日益普及、机器人辅助切片检查手术的日益广泛应用、即时组织反馈技术的日益融合、微创诊断技术的扩展以及对诊断准确性和患者安全性的日益关注。

微创手术的普及预计将显着推动智慧切片检查设备市场的成长。微创手术旨在最大程度地减少对正常身体结构的影响，而智慧切片检查设备的应用则能提高组织取样的精准度和准确性。这些设备通常整合了先进的成像技术，例如即时超音波和磁振造影（MRI）引导，使医务人员能够透过更小的切口精准定位切片检查区域。这不仅减轻了患者的不适感，也提高了诊断的准确性。例如，根据美国整形外科医师协会（ASPS）—一家总部位于美国的专业医疗协会—在2024年6月发布的公告，预计2023年微创手​​术的成长率将达到7%，比外科手术的成长率高出2%。神经调节剂注射和透明质酸填充剂注射的案例分别超过900万例和500万例。因此，微创手术的日益普及是推动智慧切片检查设备市场成长的主要动力。

智慧切片检查设备市场的主要企业正致力于开发先进的技术创新，例如多重模式乳房切片标记物，以提高病灶定位的准确性，保持长期的病灶位置可见性，并增强诊断信心。多重模式标记物是专门设计的切片检查部位标记物，可在超音波、乳房X光摄影和磁振造影扫描中保持清晰可见，使临床医生能够准确追踪切片检查部位并支持精准的后续观察评估。例如，2024年3月，总部位于美国的医疗科技公司Mamotome推出了其获得510(k)已经过核准的下一代多重模式乳房切片部位标记物LumiMARK。此标记物有三种3D形状可供选择，包括Tulip™和Rose™，可确保在各种成像模式下保持一致的可见性，并提高乳房组织和淋巴结中的长期可检测性，从而支持更准确的诊断和持续的临床决策。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球智慧切片检查设备市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
    • 数位化、云端运算、巨量资料、网路安全
  • 主要趋势
    • 影像导引切片检查系统的应用日益普及
    • 机器人辅助切片检查手术的使用日益增多
    • 即时组织回馈技术整合的进展
    • 微创诊断技术的扩展
    • 更重视诊断准确性与病人安全

第五章 终端用户产业市场分析

  • 医院
  • 诊断和影像中心
  • 学术研究机构
  • 肿瘤诊所
  • 门诊手术中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球智慧切片检查设备市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球智慧切片检查设备市场规模、对比及成长率分析
  • 全球智慧切片检查设备市场表现：规模与成长，2020-2025年
  • 全球智慧切片检查设备市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球总潜在市场（TAM）

第九章 市场细分

  • 副产品
  • 针刺切片检查器械，立体定位导丝
  • 透过引导技术
  • 超音波引导切片检查、立体定位引导切片检查、磁振造影引导切片检查等引导技术
  • 透过使用
  • 乳癌、皮肤癌、肝癌、摄护腺癌及其他用途
  • 最终用户
  • 医院、学术研究机构、诊断与影像中心
  • 按类型细分：针刺切片检查装置
  • 核心针切片装置、细针穿刺（FNA）装置、真空辅助切片检查装置
  • 按类型细分：定位线
  • 钩线定位装置、雷达定位装置、磁性定位装置

第十章 区域与国家分析

  • 全球智慧切片检查设备市场：区域分析、预测与趋势，2020-2025年、2025-2030年预测、2035年预测
  • 全球智慧切片检查设备市场：依国家/地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 智慧切片检查设备市场：竞争格局及市场占有率（2024年）
  • 智慧切片检查设备市场：公司估值矩阵
  • 智慧切片检查设备市场：公司概况
    • Becton Dickinson and Company
    • Boston Scientific Corporation
    • Hologic Inc.
    • Cook Medical Inc.
    • Medtronic Plc

第37章：其他领先和创新企业

  • Olympus Corporation, B. Braun Melsungen AG, CONMED Corporation, FUJIFILM Holdings Corporation, Argon Medical Devices Inc., SOMATEX Medical Technologies GmbH, TSK Laboratory Europe BV, INRAD Inc., Esaote SpA, Planmed Oy, Canon Medical Systems Corporation, Siemens Healthineers, General Electric Company, Intuitive Surgical Inc., Karl Storz SE And Co KG

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年智慧切片检查设备市场：提供新机会的国家
  • 2030年智慧切片检查设备市场：充满新机会的细分市场
  • 智慧切片检查设备市场展望（2030 年）：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MSBDI01_G26Q1

Smart biopsy devices are intelligent instruments designed to enhance the precision and efficiency of tissue sampling during medical procedures, often incorporating features such as image guidance, real-time feedback, or robotic assistance. These devices aim to improve diagnostic capabilities and patient outcomes, particularly in the context of cancer diagnosis and drug delivery.

The primary products within the category of smart biopsy devices include needle-based biopsy instruments, procedure trays, localization wires, and others. Needle-based biopsy instruments are tools used to extract a sample of the body's cells for laboratory analysis, collecting tissue or liquid samples from various organs such as bones, muscles, liver, and lungs. These devices employ guidance techniques such as ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance imaging-guided biopsy, and others. Smart biopsy devices find applications in various areas, including breast cancer, skin cancer, liver cancer, prostate cancer, and more. The end users of these devices include hospitals, academic and research institutes, as well as diagnostic and imaging centers.

Tariffs are impacting the smart biopsy devices market by increasing costs of imported imaging components, robotic actuators, precision needles, sensors, and control software used in advanced biopsy systems. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-precision medical components, while Asia-Pacific faces higher system integration costs. These tariffs are raising capital expenditure requirements and slowing procurement cycles. However, they are also encouraging localized manufacturing, regional supplier partnerships, and domestic innovation in smart diagnostic device development.

The smart biopsy devices market research report is one of a series of new reports from The Business Research Company that provides smart biopsy devices market statistics, including smart biopsy devices industry global market size, regional shares, competitors with a smart biopsy devices market share, detailed smart biopsy devices market segments, market trends and opportunities, and any further data you may need to thrive in the smart biopsy devices industry. This smart biopsy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart biopsy devices market size has grown strongly in recent years. It will grow from $3.01 billion in 2025 to $3.23 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to rising cancer incidence rates, increased use of minimally invasive diagnostic procedures, expansion of advanced imaging infrastructure, growing adoption of core needle biopsy techniques, improved clinician training in image-guided diagnostics.

The smart biopsy devices market size is expected to see strong growth in the next few years. It will grow to $4.32 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing demand for precision oncology diagnostics, rising investments in smart surgical technologies, expansion of robotic-assisted intervention platforms, growing focus on early disease detection, increasing integration of AI-driven diagnostic support. Major trends in the forecast period include increasing adoption of image-guided biopsy systems, rising use of robotic-assisted biopsy procedures, growing integration of real-time tissue feedback technologies, expansion of minimally invasive diagnostic techniques, enhanced focus on diagnostic accuracy and patient safety.

The adoption of minimally invasive procedures is poised to contribute significantly to the growth of the smart biopsy devices market. Minimally invasive procedures, designed to minimize disruption to the body's normal structures, benefit from the use of smart biopsy devices to enhance precision and accuracy in tissue sampling. These devices often incorporate advanced imaging technologies such as real-time ultrasound or MRI guidance, enabling healthcare professionals to target specific areas for biopsy through smaller incisions. This reduces patient trauma and enhances diagnostic accuracy. FFor instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based professional medical organization, minimally invasive procedures grew by 7 percent in 2023, surpassing the growth of surgical procedures by 2 percent, with neuromodulator injections and hyaluronic acid filler treatments reaching over 9 million and 5 million, respectively. Therefore, the growing adoption of minimally invasive procedures is a driving factor in the smart biopsy devices market.

Major companies in the smart biopsy devices market are focusing on developing advanced innovations, such as multi-modality breast biopsy markers, to enhance lesion localization, maintain long-term site visibility, and improve diagnostic confidence. Multi-modality markers are specialized biopsy site markers designed to remain clearly visible across ultrasound, mammography, and MRI, allowing clinicians to accurately track biopsy sites and support precise follow-up assessments. For instance, in March 2024, Mammotome, a US-based medical technology company, launched LumiMARK, a next-generation 510(k)-cleared breast biopsy site marker for multi-modality identification. Offered in three distinct 3D shapes-including Tulip(TM) and Rose(TM)-the marker ensures consistent visibility across imaging modalities and provides enhanced long-term detectability in both breast tissue and lymph nodes, supporting more accurate diagnosis and ongoing clinical decision-making.

In June 2023, Quest Diagnostics, a medical laboratories company, acquired Haystack Oncology for $450 million. This strategic acquisition enhances Quest Diagnostics' cancer diagnostics portfolio by incorporating Haystack's highly sensitive minimal-residual disease (MRD) testing technology based on circulating tumor DNA (ctDNA). The addition of Haystack's advanced testing capabilities allows Quest to offer improved early detection of solid tumor cancers through blood-based clinical lab services, starting in 2024. Haystack Oncology Inc. specializes in developing and utilizing advanced technologies for MRD testing in the field of cancer diagnostics.

Major companies operating in the smart biopsy devices market are Becton Dickinson and Company, Boston Scientific Corporation, Hologic Inc., Cook Medical Inc., Medtronic Plc, Olympus Corporation, B. Braun Melsungen AG, CONMED Corporation, FUJIFILM Holdings Corporation, Argon Medical Devices Inc., SOMATEX Medical Technologies GmbH, TSK Laboratory Europe B.V., INRAD Inc., Esaote SpA, Planmed Oy, Canon Medical Systems Corporation, Siemens Healthineers, General Electric Company, Intuitive Surgical Inc., Karl Storz SE And Co KG, Stryker Corporation

North America was the largest region in the smart biopsy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the smart biopsy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The smart biopsy devices market consists of revenues earned by entities by providing services such as collecting biopsy samples, real-time cancer tissue characterization, minimally invasive biopsy, and precise tissue targeting. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart biopsy devices market also includes sales of image-guided biopsy devices, core biopsy devices, bone biopsy needles and devices, and molecular biopsy devices which are used in providing collecting biopsy samples, real-time cancer tissue characterization services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Biopsy Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses smart biopsy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart biopsy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart biopsy devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Needle-Based Biopsy Instruments; Localization Wires
  • 2) By Guidance Technique: Ultrasound-Guided Biopsy; Stereotactic-Guided Biopsy; Magnetic Resonance Imaging-Guided Biopsy; Other Guidance Techniques
  • 3) By Application: Breast Cancer; Skin Cancer; Liver Cancer; Prostate Cancer; Other Applications
  • 4) By End-User: Hospitals; Academic And Research Institutes; Diagnostic And Imaging Centers
  • Subsegments:
  • 1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices; Fine Needle Aspiration (FNA) Devices; Vacuum-Assisted Biopsy Devices
  • 2) By Localization Wires: Hook Wire Localization Devices; Radar Localization Devices; Magnetic Localization Devices
  • Companies Mentioned: Becton Dickinson and Company; Boston Scientific Corporation; Hologic Inc.; Cook Medical Inc.; Medtronic Plc; Olympus Corporation; B. Braun Melsungen AG; CONMED Corporation; FUJIFILM Holdings Corporation; Argon Medical Devices Inc.; SOMATEX Medical Technologies GmbH; TSK Laboratory Europe B.V.; INRAD Inc.; Esaote SpA; Planmed Oy; Canon Medical Systems Corporation; Siemens Healthineers; General Electric Company; Intuitive Surgical Inc.; Karl Storz SE And Co KG; Stryker Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Smart Biopsy Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Smart Biopsy Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Smart Biopsy Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Smart Biopsy Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Image-Guided Biopsy Systems
    • 4.2.2 Rising Use Of Robotic-Assisted Biopsy Procedures
    • 4.2.3 Growing Integration Of Real-Time Tissue Feedback Technologies
    • 4.2.4 Expansion Of Minimally Invasive Diagnostic Techniques
    • 4.2.5 Enhanced Focus On Diagnostic Accuracy And Patient Safety

5. Smart Biopsy Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic And Imaging Centers
  • 5.3 Academic And Research Institutes
  • 5.4 Oncology Specialty Clinics
  • 5.5 Ambulatory Surgical Centers

6. Smart Biopsy Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Smart Biopsy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Smart Biopsy Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Smart Biopsy Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Smart Biopsy Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Smart Biopsy Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Smart Biopsy Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Smart Biopsy Devices Market Segmentation

  • 9.1. Global Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Needle-Based Biopsy Instruments, Localization Wires
  • 9.2. Global Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques
  • 9.3. Global Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications
  • 9.4. Global Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers
  • 9.5. Global Smart Biopsy Devices Market, Sub-Segmentation Of Needle-Based Biopsy Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices
  • 9.6. Global Smart Biopsy Devices Market, Sub-Segmentation Of Localization Wires, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices

10. Smart Biopsy Devices Market Regional And Country Analysis

  • 10.1. Global Smart Biopsy Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Smart Biopsy Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Smart Biopsy Devices Market

  • 11.1. Asia-Pacific Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Smart Biopsy Devices Market

  • 12.1. China Smart Biopsy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Smart Biopsy Devices Market

  • 13.1. India Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Smart Biopsy Devices Market

  • 14.1. Japan Smart Biopsy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Smart Biopsy Devices Market

  • 15.1. Australia Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Smart Biopsy Devices Market

  • 16.1. Indonesia Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Smart Biopsy Devices Market

  • 17.1. South Korea Smart Biopsy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Smart Biopsy Devices Market

  • 18.1. Taiwan Smart Biopsy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Smart Biopsy Devices Market

  • 19.1. South East Asia Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Smart Biopsy Devices Market

  • 20.1. Western Europe Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Smart Biopsy Devices Market

  • 21.1. UK Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Smart Biopsy Devices Market

  • 22.1. Germany Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Smart Biopsy Devices Market

  • 23.1. France Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Smart Biopsy Devices Market

  • 24.1. Italy Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Smart Biopsy Devices Market

  • 25.1. Spain Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Smart Biopsy Devices Market

  • 26.1. Eastern Europe Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Smart Biopsy Devices Market

  • 27.1. Russia Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Smart Biopsy Devices Market

  • 28.1. North America Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Smart Biopsy Devices Market

  • 29.1. USA Smart Biopsy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Smart Biopsy Devices Market

  • 30.1. Canada Smart Biopsy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Smart Biopsy Devices Market

  • 31.1. South America Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Smart Biopsy Devices Market

  • 32.1. Brazil Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Smart Biopsy Devices Market

  • 33.1. Middle East Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Smart Biopsy Devices Market

  • 34.1. Africa Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Smart Biopsy Devices Market, Segmentation By Product, Segmentation By Guidance Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Smart Biopsy Devices Market Regulatory and Investment Landscape

36. Smart Biopsy Devices Market Competitive Landscape And Company Profiles

  • 36.1. Smart Biopsy Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Smart Biopsy Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Smart Biopsy Devices Market Company Profiles
    • 36.3.1. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Cook Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis

37. Smart Biopsy Devices Market Other Major And Innovative Companies

  • Olympus Corporation, B. Braun Melsungen AG, CONMED Corporation, FUJIFILM Holdings Corporation, Argon Medical Devices Inc., SOMATEX Medical Technologies GmbH, TSK Laboratory Europe B.V., INRAD Inc., Esaote SpA, Planmed Oy, Canon Medical Systems Corporation, Siemens Healthineers, General Electric Company, Intuitive Surgical Inc., Karl Storz SE And Co KG

38. Global Smart Biopsy Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Smart Biopsy Devices Market

40. Smart Biopsy Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Smart Biopsy Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Smart Biopsy Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Smart Biopsy Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer